Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

v3.22.2.2
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Subordinate Voting Shares
Common Stock
Super Voting Shares
Common Stock
Multiple Voting Shares
Common Stock
Subordinate Voting Shares
Total Jushi Shareholders' Equity
Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2020     149,000 4,000,000 132,396,064        
Balance at beginning of period at Dec. 31, 2020 $ 2,423         $ (524) $ 262,145 $ (262,669) $ 2,947
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Offerings (in shares)         13,685,000        
Offerings 85,660         85,660 85,660    
Purchase of non-controlling interests (in shares)         500,000        
Purchase of non-controlling interests 0         1,562 1,562   (1,562)
Shares issued for acquisition (in shares)         49,348        
Shares issued for acquisition 368         368 368    
Shares issued upon exercise of warrants (in shares)         3,898,180        
Shares issued upon exercise of warrants 13,135         13,135 13,135    
Shares issued upon exercise of stock options (in shares)         15,000        
Shares issued upon exercise of stock options 30         30 30    
Share-based compensation 4,013         4,013 4,013    
Net income (loss) (31,051)         (30,876)   (30,876) (175)
Balance at end of period (in shares) at Mar. 31, 2021     149,000 4,000,000 150,543,592        
Balance at end of period at Mar. 31, 2021 74,578         73,368 366,913 (293,545) 1,210
Balance at beginning of period (in shares) at Dec. 31, 2020     149,000 4,000,000 132,396,064        
Balance at beginning of period at Dec. 31, 2020 2,423         (524) 262,145 (262,669) 2,947
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 11,268                
Balance at end of period (in shares) at Sep. 30, 2021     0 0 182,204,274        
Balance at end of period at Sep. 30, 2021 165,948         164,990 415,965 (250,975) 958
Balance at beginning of period (in shares) at Mar. 31, 2021     149,000 4,000,000 150,543,592        
Balance at beginning of period at Mar. 31, 2021 74,578         73,368 366,913 (293,545) 1,210
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued for restricted stock grants (in shares)         34,815        
Shares issued upon exercise of warrants (in shares)         1,476,869        
Shares issued upon exercise of warrants 3,144         3,144 3,144    
Shares issued upon exercise of stock options (in shares)         14,173        
Shares issued upon exercise of stock options 20         20 20    
Share-based compensation 2,733         2,733 2,733    
Net income (loss) 2,636         2,826   2,826 (190)
Balance at end of period (in shares) at Jun. 30, 2021     149,000 4,000,000 152,069,449        
Balance at end of period at Jun. 30, 2021 83,111         82,091 372,810 (290,719) 1,020
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of Super Voting Shares and Multiple Voting Shares (in shares)     (149,000) (4,000,000) 18,900,000        
Shares issued for acquisition (in shares)         8,700,000        
Shares issued for acquisition 35,670         35,670 35,670    
Shares issued upon exercise of warrants (in shares)         2,437,974        
Shares issued upon exercise of warrants 5,189         5,189 5,189    
Shares issued upon exercise of stock options (in shares)         96,851        
Shares issued upon exercise of stock options 62         62 62    
Share-based compensation 2,234         2,234 2,234    
Net income (loss) 39,682         39,744   39,744 (62)
Balance at end of period (in shares) at Sep. 30, 2021     0 0 182,204,274        
Balance at end of period at Sep. 30, 2021 165,948         164,990 415,965 (250,975) 958
Balance at beginning of period (in shares) at Dec. 31, 2021     0 0 182,707,359        
Balance at beginning of period at Dec. 31, 2021 180,983         182,370 424,788 (242,418) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Offerings (in shares)         3,717,392        
Offerings 13,680         13,680 13,680    
Shares issued for acquisition (in shares)         527,704        
Shares issued for acquisition 1,594         1,594 1,594    
Shares issued for restricted stock grants (in shares)         5,952        
Shares issued upon exercise of warrants (in shares)         2,676,303        
Shares issued upon exercise of warrants 9,693         9,693 9,693    
Shares issued upon exercise of stock options (in shares)         93,915        
Share-based compensation 6,964         6,964 6,964    
Net income (loss) (19,757)         (19,757)   (19,757)  
Balance at end of period (in shares) at Mar. 31, 2022     0 0 189,728,625        
Balance at end of period at Mar. 31, 2022 193,157         194,544 456,719 (262,175) (1,387)
Balance at beginning of period (in shares) at Dec. 31, 2021     0 0 182,707,359        
Balance at beginning of period at Dec. 31, 2021 $ 180,983         182,370 424,788 (242,418) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued upon exercise of warrants (in shares)   3,176,601              
Shares issued upon exercise of stock options (in shares) 274,998                
Net income (loss) $ (62,387)                
Balance at end of period (in shares) at Sep. 30, 2022     0 0 195,769,605        
Balance at end of period at Sep. 30, 2022 177,458         178,845 483,650 (304,805) (1,387)
Balance at beginning of period (in shares) at Mar. 31, 2022     0 0 189,728,625        
Balance at beginning of period at Mar. 31, 2022 193,157         194,544 456,719 (262,175) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued for acquisition (in shares)         4,662,384        
Shares issued for acquisition 13,573         13,573 13,573    
Shares issued for service received (in shares)         101,082        
Shares issued for service received 294         294 294    
Shares issued upon exercise of warrants (in shares)         167,560        
Shares issued upon exercise of warrants 322         322 322    
Shares issued upon exercise of stock options (in shares)         1,294        
Shares canceled upon forfeiture of non-vested restricted stock (in shares)         (7,813)        
Share-based compensation 4,684         4,684 4,684    
Net income (loss) 12,066         12,066   12,066  
Balance at end of period (in shares) at Jun. 30, 2022     0 0 194,653,132        
Balance at end of period at Jun. 30, 2022 224,096         225,483 475,592 (250,109) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued for acquisition (in shares)         888,880        
Shares issued for acquisition 1,529         1,529 1,529    
Shares issued for service received (in shares)         13,334        
Shares issued for service received 23         23 23    
Shares issued for restricted stock grants (in shares)         81,000        
Shares issued upon exercise of warrants (in shares)         332,738        
Shares issued upon exercise of warrants 564         564 564    
Shares issued upon exercise of stock options (in shares)         20,000        
Shares issued upon exercise of stock options 26         26 26    
Shares canceled upon forfeiture of non-vested restricted stock (in shares)         (219,479)        
Collection of note receivable from employee shareholder 450         450 450    
Share-based compensation 5,466         5,466 5,466    
Net income (loss) (54,696)         (54,696)      
Balance at end of period (in shares) at Sep. 30, 2022     0 0 195,769,605        
Balance at end of period at Sep. 30, 2022 $ 177,458         $ 178,845 $ 483,650 $ (304,805) $ (1,387)